Atara Biotherapeutics Inc (ATRA)

11:02 AM

FDA accepts Atara’s BLA for tab-cel with priority review - Investing.com

11:02 AM

10:49 AM

Atara gets FDA priority review for Tabelecleucel application - Seeking Alpha

10:49 AM

09:18 AM

FDA Accepts Atara Biotherapeutics' BLA for Tabelecleucel (ATRA) | ATRA Stock News - GuruFocus

09:18 AM

09:15 AM

Atara Biotherapeutics stock jumps after FDA accepts BLA for tab-cel - Investing.com Australia

09:15 AM

08:26 AM

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority - GuruFocus

08:26 AM

08:21 AM

FDA Accepts Atara Biotherapeutics' BLA for Tabelecleucel | ATRA Stock News - GuruFocus

08:21 AM

08:00 AM

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease - Business Wire

08:00 AM

Jul 23, 2025

Innovation Ltd Panacea Buys 19,335 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Stock - Defense World

Jul 23, 2025

Jul 23, 2025

Atara Biotherapeutics Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Atara gains after insider purchase - MSN

Jul 23, 2025

Jul 23, 2025

Is Atara Biotherapeutics Inc. a good long term investmentConsistent triple-digit returns - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What analysts say about Atara Biotherapeutics Inc. stockFree Stock Market Query - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Atara Biotherapeutics (ATRA) Shares Surge After Insider Purchase - GuruFocus

Jul 22, 2025

Jul 22, 2025

What drives Atara Biotherapeutics Inc. stock priceSuperior stock selection - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Atara stock gains after insider purchase (ATRA:NASDAQ) - Seeking Alpha

Jul 22, 2025

Jul 20, 2025

(ATRA) Trading Advice - news.stocktradersdaily.com

Jul 20, 2025

Jul 15, 2025

How Atara Biotherapeutics Inc. stock performs during market volatilityDaily Breakout Picks - Newser

Jul 15, 2025

Jul 15, 2025

Why Atara Biotherapeutics Inc. stock attracts strong analyst attentionFree Discussion Group - Newser

Jul 15, 2025

Jul 15, 2025

What makes Atara Biotherapeutics Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025

Jul 15, 2025

Pierre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc. - PR Newswire

Jul 15, 2025

Jul 15, 2025

Major FDA Development: Pierre Fabre Assumes Control of Atara's EBV Cell Therapy Program After BLA Resubmission - Stock Titan

Jul 15, 2025

Jul 14, 2025

Atara Biotherapeutics Resubmits BLA for Tab-cel to FDA - TipRanks

Jul 14, 2025

Jul 14, 2025

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®) | ATRA Stock News - GuruFocus

Jul 14, 2025

Jul 14, 2025

Atara Biotherapeutics provides regulatory and business updates on tabelecleucel (tab-cel) - MarketScreener

Jul 14, 2025

Jul 14, 2025

Atara resubmits tabelecleucel BLA to FDA for EBV-positive PTLD By Investing.com - Investing.com Canada

Jul 14, 2025

Jul 14, 2025

Atara resubmits tabelecleucel BLA to FDA for EBV-positive PTLD - Investing.com

Jul 14, 2025

Jul 14, 2025

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel - Business Wire

Jul 14, 2025

Jul 10, 2025

(ATRA) Technical Data - news.stocktradersdaily.com

Jul 10, 2025

Jul 08, 2025

We Might See A Profit From Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Soon - simplywall.st

Jul 08, 2025

Jun 30, 2025

Atara Biotherapeutics, Inc.(NasdaqGS: ATRA) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025

Jun 11, 2025

Atara Biotherapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 11, 2025

Jun 06, 2025

Long Term Trading Analysis for (ATRA) - news.stocktradersdaily.com

Jun 06, 2025

Jun 06, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 06, 2025

Jun 04, 2025

Northern Trust Corp Purchases New Position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) - Defense World

Jun 04, 2025

Jun 02, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Short Interest Update - Defense World

Jun 02, 2025